Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial

de Greeff, 2010, Pertussis disease burden in the household: how to protect young infants, Clin Infect Dis, 50, 1339, 10.1086/652281 2014, World Health Organization meeting of the strategic advisory group of experts on immunization, April 2014—conclusions and recommendations, Wkly Epidemiol Rec, 89, 221 van Alebeek, 2017 Malek, 1996, Evolution of maternofetal transport of immunoglobulins during human pregnancy, Am J Reprod Immunol, 36, 248, 10.1111/j.1600-0897.1996.tb00172.x Abu Raya, 2014, The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study, Vaccine, 32, 5787, 10.1016/j.vaccine.2014.08.038 Munoz, 2014, Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial, JAMA, 311, 1760, 10.1001/jama.2014.3633 Hoang, 2016, Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial pertussis vaccination during pregnancy, Vaccine, 34, 151, 10.1016/j.vaccine.2015.10.098 Maertens, 2016, Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study, Vaccine, 34, 142, 10.1016/j.vaccine.2015.10.100 Gall, 2011, Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels, Am J Obstet Gynecol, 204, 334.e1, 10.1016/j.ajog.2010.11.024 Amirthalingam, 2016, Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction, Clin Infect Dis, 63, S236, 10.1093/cid/ciw559 Amirthalingam, 2014, Effectiveness of maternal pertussis vaccination in England: an observational study, Lancet, 384, 1521, 10.1016/S0140-6736(14)60686-3 Jones, 2013, Specific antibodies against vaccine-preventable infections: a mother-infant cohort study, BMJ Open, 3, e002473, 10.1136/bmjopen-2012-002473 Ladhani, 2015, Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator, Clin Infect Dis, 61, 1637, 10.1093/cid/civ695 Hardy-Fairbanks, 2013, Immune responses in infants whose mothers received Tdap vaccine during pregnancy, Pediatr Infect Dis J, 32, 1257, 10.1097/INF.0b013e3182a09b6a Abu Raya, 2017, Pertussis and influenza immunisation during pregnancy: a landscape review, Lancet Infect Dis, 17, e209, 10.1016/S1473-3099(17)30190-1 Voysey, 2017, The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis, JAMA Pediatr, 171, 637, 10.1001/jamapediatrics.2017.0638 van Gageldonk, 2008, Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus, J Immunol Methods, 335, 79, 10.1016/j.jim.2008.02.018 Markey, 2018 Wijmenga-Monsuur, 2015, Direct comparison of immunogenicity induced by 10- or 13-valent pneumococcal conjugate vaccine around the 11-month booster in dutch infants, PLoS One, 10, e0144739, 10.1371/journal.pone.0144739 van der Klis, 2009, Second national serum bank for population-based seroprevalence studies in the Netherlands, Neth J Med, 67, 301 Storsaeter, 2003, Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis, Vaccine, 21, 3542, 10.1016/S0264-410X(03)00407-9 Spijkerman, 2013, Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial, JAMA, 310, 930, 10.1001/jama.2013.228052 Siegrist, 2009, B-cell responses to vaccination at the extremes of age, Nat Rev Immunol, 9, 185, 10.1038/nri2508 Halperin, 2018, A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response, Clin Infect Dis, 67, 1063, 10.1093/cid/ciy244 2011, MMWR Morb Mortal Wkly Rep, 60, 1424 2013, Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women. Advisory Committee on Immunization Practices (ACIP), 2012, MMWR Morb Mortal Wkly Rep, 62, 131 Healy, 2013, Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants, Clin Infect Dis, 56, 539, 10.1093/cid/cis923 Eberhardt, 2016, Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis, Clin Infect Dis, 62, 829, 10.1093/cid/ciw027